Agile Therapeutics, Inc.

OTCPK:AGRX Stock Report

Market Cap: US$10.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Agile Therapeutics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Agile Therapeutics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth23.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Agile appoints chief commercial officer from within ranks amid leadership revamp

Oct 10

Agile gains as H.C. Wainwright sees 630% upside potential

Jul 11

Agile Therapeutics prices $24M upsized stock offering

Jul 01

Agile Therapeutics: Twirla's Lackluster Launch Forces Me To Change My Strategy

Apr 04

Agile Therapeutics: Bullish On Capitulation And Max Pain

Oct 19

Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy

Jul 30

Agile Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 06

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Feb 25
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Agile Therapeutics issues cash projection at JP Morgan healthcare conference

Jan 14

Assessing Agile Therapeutics

Jan 10

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Jan 04
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Agile Therapeutics announces peer-reviewed publication of late-stage study for Twirla contraception patch

Nov 30

Agile Therapeutics EPS in-line

Nov 12

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Agile Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:AGRX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202422-16-2-2N/A
3/31/202421-8-10-10N/A
12/31/202320-14-10-10N/A
9/30/202320-14-11-11N/A
6/30/202316-19-28-28N/A
3/31/202313-20-23-23N/A
12/31/202211-25-36-36N/A
9/30/20228-41-51-51N/A
6/30/20227-52-53-53N/A
3/31/20226-64-66-65N/A
12/31/20214-71-65-65N/A
9/30/20213-69-66-66N/A
6/30/20212-68-63-63N/A
3/31/20211-61-54-54N/A
12/31/20201-52-48-47N/A
9/30/2020N/A-40-34-33N/A
6/30/2020N/A-29-23-23N/A
3/31/2020N/A-22-19-19N/A
12/31/2019N/A-19-16-16N/A
9/30/2019N/A-16-16-16N/A
6/30/2019N/A-16-14-14N/A
3/31/2019N/A-18-16-16N/A
12/31/2018N/A-20-17-17N/A
9/30/2018N/A-22-20-20N/A
6/30/2018N/A-26-24-23N/A
3/31/2018N/A-28N/A-24N/A
12/31/2017N/A-28N/A-25N/A
9/30/2017N/A-27N/A-22N/A
6/30/2017N/A-28N/A-22N/A
3/31/2017N/A-29N/A-23N/A
12/31/2016N/A-29N/A-23N/A
9/30/2016N/A-27N/A-25N/A
6/30/2016N/A-29N/A-25N/A
3/31/2016N/A-29N/A-27N/A
12/31/2015N/A-30N/A-25N/A
9/30/2015N/A-33N/A-26N/A
6/30/2015N/A-30N/A-26N/A
3/31/2015N/A-25N/A-21N/A
12/31/2014N/A-16N/A-15N/A
9/30/2014N/A-12N/A-11N/A
6/30/2014N/A-9N/A-7N/A
3/31/2014N/A-10N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AGRX's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if AGRX's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if AGRX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AGRX's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if AGRX's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AGRX's Return on Equity is forecast to be high in 3 years time


Discover growth companies